Browse by Poster Title

• All
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z
• #

---

• E
• Favorite
  459

  Early Phase Selection of a Controlled Release Amorphous Dispersion Formulation
  
  
• Favorite
  266

  Effect of freezing conditions, cryoprotectant concentrations, and PVP on crystallization
  
  
• Favorite
  470

  Effect of Hydroxypropyl Cellulose Grade on the Tablet Characteristics in Continuous Granulation
  
  
• Favorite
  177

  Effect of ionizable lipid source on the quality attributes of siRNA lipid nanoparticle therapeutics
  
  
• Favorite
  366

  Effect of Pegylayion on liposomal adhesion on breast cancer tumor
  
  
• Favorite
  348

  Effective screening of LNP formulations with centrifugal microfluidics devices
  
  
• Favorite
  117

  Efficient and controlled drug release from PEDOT synthesised via surface-tethered dopant templating
  
  
• Favorite
  457

  Efficient Manufacturing of Delayed Release Minitablets using a Seal and Enteric Coating Approach
  
  
• Favorite
  323

  Electrospinning of nanofibers and the perspectives for dermatological application
  
  
• Favorite
  506

  Electrosprayed Dry Powder Inhaler (DPI) Formulations of Bevacizumab for the Treatment of NSCLC
  
  
• Favorite
  221

  Electrospun Nanofibers for Dual Probiotic and Antibiotic Delivery Targeting Bacterial Vaginosis
  
  
• Favorite
  466

  Enabling Oral Delivery of Salmon Calcitonin via SNEDDS: Impact on Protection and Activity
  
  
• Favorite
  123

  Endoplasmic reticulum stress-based approach for reprogramming tumor-derived exosome
  
  
• Favorite
  335

  Endoscopic Delivery of Regorafenib-Curcumin Microparticles to Locally Treat Colorectal Cancer
  
  
• Favorite
  270

  End-To-End Process for Improved Purity, Combined With Innovative Analytics of LNP-Based Therapeutics
  
  
• Favorite
  320

  Engineered Nanobubbles for Inducing Unprogrammed Necrosis in Cancer Immunortherapy
  
  
• Favorite
  391

  Engineered Nanovaccines for STING-Activated Antigen Cross-Presentation in Cancer Immunotherapy
  
  
• Favorite
  328

  Engineering Extended-Release Profiles for Biologics via Crosslinking of Poloxamer 407 Hydrogels
  
  
• Favorite
  129

  Engineering Metal-Organic Framework-biopolymer-based Hydrogels for Controlled Therapeutic Delivery
  
  
• Favorite
  259

  Engineering the structural and optical properties of gold nanostars with microfluidics
  
  
• Favorite
  314

  Enhanced anti-sarcopenic activity of perindopril erbumine using ultradeformable liposomes
  
  
• Favorite
  325

  Enhanced Solubility & Anti-Dilution Properties of Lipophilic Drugs with Solid Micellar Nanoparticles
  
  
• Favorite
  495

  Enhanced Transdermal Permeation of Diclofenac Sodium using Mango Seed Kernel Starch Nanoparticles
  
  
• Favorite
  296

  Enhancing mRNA-LNP Efficacy: Investigating the Role of Ionisable and Cationic Lipid Combinations
  
  
• Favorite
  216

  Enhancing PARP inhibitors efficacy in BRCA1-deficient tumors with radiation-guided nanoparticles
  
  
• Favorite
  471

  Enhancing pH-responsive drug release in gastrointestinal environment by alginate–CMC/CAP microbeads
  
  
• Favorite
  482

  Enhancing the storage stability and delivery of extracellular vesicles by using microneedles
  
  
• Favorite
  473

  Enhancing Therapeutic Efficacy and Immune Response with Bispecific Gold Nanoparticles in Cancer
  
  
• Favorite
  252

  Enlighting the black box: Nanocarrier formation inside microfluidic mixing devices
  
  
• Favorite
  462

  Enteric-coated spherical granules for dual delivery of orlistat & acarbose with diverging properties
  
  
• Favorite
  224

  Enzyme-activated MRI contrast agent for tumor-specific gadolinium delivery
  
  
• Favorite
  142

  Erythrocyte membrane biomimetic nanoparticles for Dapagliflozin delivery in the fibrotic heart
  
  
• Favorite
  355

  Evaluation of Apisolex™ for Parenteral Use: Solubilizing Poorly Soluble Small Molecules and PROTACs
  
  
• Favorite
  386

  Evaluation of the biocidal activity of Origanum vulgare L. essential oil in nanoemulsion
  
  
• Favorite
  364

  Evaluation of triazine-based lipid nanoparticle (LNP) formulation for mRNA delivery in a mouse model
  
  
• Favorite
  284

  Evaluation of Vaccine Induced Antitumor Response of Cationic Nanoparticles in Colorectal Cancer
  
  
• Favorite
  509

  Ex vivo platform using viable human skin to study subcutaneous administration of macromolecules
  
  
• Favorite
  359

  Exosome-Liposome Fusion System for Targeted Treatment of MCAO-Induced Brain Injury
  
  
• Favorite
  116

  Exploiting Metabolite-Presenting Molecules for Targeted Therapies
  
  
• Favorite
  463

  Exploring Orodispersible Films Containing the PROTAC ARV-110 in Solvent Casting using PVA
  
  
• Favorite
  159

  Exploring Substrate Stiffness and YAP/TAZ Pathways in Non-Viral Gene Delivery Applications
  
  
• Favorite
  375

  Exploring the Impact of Iron Availability on Antibiotic Resistance in Mycobacterium Species